Single_JJ
point_NN
estimation_NN
of_IN
glucocorticoid_NN
receptors_NNS
in_IN
lymphocytes_NNS
of_IN
normal_JJ
subjects_NNS
and_CC
of_IN
children_NNS
under_IN
long_JJ
term_NN
glucocorticoid_NN
treatment_NN
._.

A_DT
single_JJ
point_NN
assay_NN
of_IN
glucocorticoid_NN
receptors_NNS
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
in_IN
human_JJ
lymphocytes_NNS
based_VBN
on_IN
the_DT
measurement_NN
of_IN
specific_JJ
dexamethasone_NN
binding_NN
has_VBZ
been_VBN
developed_VBN
and_CC
compared_VBN
with_IN
a_DT
common_JJ
multi-point_JJ
Scatchard_NN
analysis_NN
._.

The_DT
assay_NN
conditions_NNS
-_:
concentration_NN
of_IN
the_DT
ligand_NN
20_CD
nmol\/l_NN
,_,
incubation_NN
time_NN
2_CD
h_NN
and_CC
the_DT
cell_NN
count_NN
2-6_NN
mil_NN
._.
cells\/tube_NNS
in_IN
the_DT
assay_NN
volume_NN
0.25_CD
ml_NN
were_VBD
found_VBN
to_TO
be_VB
optimal_JJ
._.

An_DT
attempt_NN
was_VBD
also_RB
undertaken_VBN
to_TO
use_VB
a_DT
cell_NN
harvester_NN
for_IN
the_DT
separation_NN
of_IN
cells_NNS
from_IN
unbound_JJ
ligand_NN
._.

Though_IN
specifically_RB
bound_VBD
dexamethasone_NN
measured_VBN
by_IN
whole-cell_JJ
assay_NN
and_CC
that_DT
using_VBG
cell_NN
harvester_NN
correlated_VBN
well_RB
,_,
almost_RB
by_IN
one_CD
order_NN
lower_JJR
values_NNS
obtained_VBN
with_IN
the_DT
latter_JJ
method_NN
render_VBP
it_PRP
non-applicable_JJ
for_IN
receptor_NN
quantitation_NN
._.

The_DT
results_NNS
from_IN
9_CD
healthy_JJ
volunteers_NNS
-LRB-_-LRB-
average_JJ
GR_NN
concentration_NN
7131_NN
+_CC
\/_NN
-_:
1256_CD
sites\/cell_NNS
-RRB-_-RRB-
correlated_VBD
excellently_RB
with_IN
those_DT
obtained_VBN
by_IN
the_DT
Scatchard_NN
analysis_NN
._.

The_DT
single_JJ
point_NN
assay_NN
has_VBZ
been_VBN
also_RB
applied_VBN
for_IN
determination_NN
of_IN
GH_NN
in_IN
10_CD
children_NNS
treated_VBN
with_IN
large_JJ
doses_NNS
of_IN
prednisone_NN
._.

The_DT
average_JJ
values_NNS
from_IN
healthy_JJ
volunteers_NNS
did_VBD
not_RB
differ_VB
significantly_RB
from_IN
those_DT
found_VBN
in_IN
these_DT
children_NNS
,_,
though_IN
much_RB
broader_JJR
range_NN
was_VBD
found_VBN
in_IN
patients_NNS
._.

